Adipolin protects against renal injury via PPARα-dependent reduction of inflammasome activation

[1]  Y. Hattori.  Beneficial effects on kidney during treatment with sodium-glucose cotransporter 2 inhibitors: proposed role of ketone utilization , 2021, Heart Failure Reviews.

[2]  T. Murohara,et al.  Adipolin/C1q/Tnf-related protein 12 prevents adverse cardiac remodeling after myocardial infarction , 2020, PloS one.

[3]  Jiajia Xu,et al.  Reduced serum CTRP12 levels in type 2 diabetes are associated with renal dysfunction , 2020, International Urology and Nephrology.

[4]  H. Maegawa,et al.  SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition. , 2020, Cell metabolism.

[5]  A. Esteghamati,et al.  Role of type 2 diabetes and hemodialysis in serum adipolin concentrations: A preliminary study , 2019, Hemodialysis international. International Symposium on Home Hemodialysis.

[6]  N. Câmara,et al.  NLRP3 inflammasome inhibition ameliorates tubulointerstitial injury in the remnant kidney model , 2018, Laboratory Investigation.

[7]  A. Lau,et al.  Macrophage Uptake of Necrotic Cell DNA Activates the AIM2 Inflammasome to Regulate a Proinflammatory Phenotype in CKD. , 2018, Journal of the American Society of Nephrology : JASN.

[8]  P. Scherer,et al.  Immunologic and endocrine functions of adipose tissue: implications for kidney disease , 2018, Nature Reviews Nephrology.

[9]  S. M. Matos,et al.  Obesity and kidney disease. , 2017, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[10]  Connie M. Rhee,et al.  The dual roles of obesity in chronic kidney disease: a review of the current literature , 2016, Current opinion in nephrology and hypertension.

[11]  N. Rifai,et al.  Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease , 2015, BMC Nephrology.

[12]  K. Ma,et al.  Involvement of endoplasmic reticulum stress in angiotensin II-induced NLRP3 inflammasome activation in human renal proximal tubular cells in vitro , 2015, Acta Pharmacologica Sinica.

[13]  T. Murohara,et al.  Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model. , 2015, Journal of the American Society of Nephrology : JASN.

[14]  T. Noda,et al.  ASC in renal collecting duct epithelial cells contributes to inflammation and injury after unilateral ureteral obstruction. , 2014, The American journal of pathology.

[15]  E. Verdin,et al.  Ketone bodies as signaling metabolites , 2014, Trends in Endocrinology & Metabolism.

[16]  T. Murohara,et al.  Transcriptional Regulation of an Insulin-Sensitizing Adipokine Adipolin/CTRP12 in Adipocytes by Krüppel-Like Factor 15 , 2013, PloS one.

[17]  T. Ikizler,et al.  Obesity in CKD--what should nephrologists know? , 2013, Journal of the American Society of Nephrology : JASN.

[18]  V. Jha,et al.  Chronic kidney disease: global dimension and perspectives , 2013, The Lancet.

[19]  R. Schugar,et al.  Ketone body metabolism and cardiovascular disease. , 2013, American journal of physiology. Heart and circulatory physiology.

[20]  T. Murohara,et al.  Regulation of adipolin/CTRP12 cleavage by obesity. , 2012, Biochemical and biophysical research communications.

[21]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[22]  L. Cebotaru,et al.  C1q/TNF-related Protein-12 (CTRP12), a Novel Adipokine That Improves Insulin Sensitivity and Glycemic Control in Mouse Models of Obesity and Diabetes* , 2012, The Journal of Biological Chemistry.

[23]  T. Murohara,et al.  Adipolin/C1qdc2/CTRP12 Protein Functions as an Adipokine That Improves Glucose Metabolism* , 2011, The Journal of Biological Chemistry.

[24]  T. Uzu,et al.  Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis. , 2011, Kidney international.

[25]  K. Walsh,et al.  Adipokines in inflammation and metabolic disease , 2011, Nature Reviews Immunology.

[26]  J. Tschopp,et al.  The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. , 2010, Journal of the American Society of Nephrology : JASN.

[27]  W. Branham,et al.  Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury. , 2009, Kidney international.

[28]  K. Meldrum,et al.  IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis. , 2009, Kidney international.

[29]  Bicheng Liu,et al.  Albumin caused the increasing production of angiotensin II due to the dysregulation of ACE/ACE2 expression in HK2 cells. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[30]  S. Kihara,et al.  Adiponectin Protects Against Angiotensin II–Induced Cardiac Fibrosis Through Activation of PPAR-&agr; , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[31]  B. Falkner,et al.  Adiponectin regulates albuminuria and podocyte function in mice. , 2008, The Journal of clinical investigation.

[32]  S. Rong,et al.  Leptin is a coactivator of TGF-beta in unilateral ureteral obstructive kidney disease. , 2007, American journal of physiology. Renal physiology.

[33]  S. Kihara,et al.  Exacerbation of Albuminuria and Renal Fibrosis in Subtotal Renal Ablation Model of Adiponectin-Knockout Mice , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[34]  Joseph K McLaughlin,et al.  Obesity and risk for chronic renal failure. , 2006, Journal of the American Society of Nephrology : JASN.

[35]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[36]  B. Staels,et al.  Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors in Lipid Metabolism and Atherosclerosis , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[37]  B. Staels,et al.  Peroxisome proliferator-activated receptors in inflammation control. , 2001, The Journal of endocrinology.

[38]  G. Gil-Gómez,et al.  Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. , 1994, The Journal of biological chemistry.

[39]  P. A. Crawford,et al.  The ketone metabolite β-hydroxybutyrate blocks NLRP 3 inflammasome – mediated inflammatory disease , 2015 .